SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-245724
Filing Date
2023-09-28
Accepted
2023-09-28 16:38:55
Documents
14
Period of Report
2023-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d537767d8k.htm   iXBRL 8-K 23919
2 EX-99.1 d537767dex991.htm EX-99.1 30805
6 GRAPHIC g537767g0929014206413.jpg GRAPHIC 6221
  Complete submission text file 0001193125-23-245724.txt   193559

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20230928.xsd EX-101.SCH 2875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20230928_lab.xml EX-101.LAB 17927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20230928_pre.xml EX-101.PRE 11255
8 EXTRACTED XBRL INSTANCE DOCUMENT d537767d8k_htm.xml XML 3326
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 231290343
SIC: 2834 Pharmaceutical Preparations